Modulating the Inflammasome Pathway: Mechanisms and Therapeutic Potential

The innate immune system serves as the first line of defense against pathogens, with inflammasome complexes playing a pivotal role in orchestrating the inflammatory response. Among these, the NLRP3 inflammasome has emerged as a central regulator of inflammation, implicated in a vast array of pathologies ranging from autoimmune disorders and metabolic diseases to neurodegeneration. However, despite significant progress in understanding inflammasome biology, the translation of these insights into effective clinical therapies remains a significant challenge.This Research Topic aims to bridge the gap between fundamental mechanistic discovery and clinical application. We seek to highlight the latest advances in the regulation, modulation, and therapeutic targeting of inflammasome pathways. As the field moves beyond broad anti-inflammatory strategies toward precision medicine, understanding the nuances of inflammasome assembly, activation, and inhibition is critical for developing next-generation therapeutics.We invite investigators to contribute Original Research, Review, Mini-Review, and Perspective articles that explore the multifaceted nature of inflammasome pharmacology. The scope of this collection encompasses not only the well-studied NLRP3 complex but also other emerging sensors (e.g., NLRP1, NLRC4, AIM2) and their roles in disease pathogenesis.Specific themes of interest include, but are not limited to:Molecular Mechanisms of Regulation: New insights into the post-translational modifications, structural dynamics, and upstream signaling pathways that govern inflammasome assembly and activation.Novel Therapeutic Agents: Discovery and characterization of small molecule inhibitors, biologics, and natural products that distinctively target inflammasome components or their downstream effectors (IL-1β, IL-18, Gasdermin D).Clinical Translation and Resistance: Evaluation of therapeutic efficacy in preclinical models and clinical trials, including investigations into mechanisms of drug resistance and the challenges of bioavailability.Biomarker Development: Identification and validation of reliable biomarkers for monitoring inflammasome activity and stratifying patients who are most likely to benefit from inflammasome-targeted therapies.Disease-Specific Applications: The role of inflammasome modulation in specific contexts such as rheumatoid arthritis, inflammatory bowel disease (IBD), gout, neuroinflammatory conditions (e.g., Alzheimer’s, Parkinson’s), and metabolic syndromes.By assembling a diverse collection of studies, this Research Topic aims to provide a comprehensive roadmap of the current landscape and future directions of inflammasome-targeted pharmacology. Topic editors: Elisa Benetti, Ana Belén Carrillo Gálvez Source: https://www.frontiersin.org/research-topics/78296/modulating-the-inflammasome-pathway-mechanisms-and-therapeutic-potential